Search

Your search keyword '"Hoetzenecker W"' showing total 239 results
Start Over Author "Hoetzenecker W"
239 results on '"Hoetzenecker W"'

1. Influencing factors on the safety and effectiveness of venom immunotherapy

Author

Arzt-Gradwohl, L, primary, Annik Herzog, S, additional, Aberer, W, additional, Alfaya Arias, T, additional, Antolín-Amérigo, D, additional, Bonadonna, P, additional, Boni, E, additional, Bożek, A, additional, Chełmińska, M, additional, Ernst, B, additional, Frelih, N, additional, Gawlik, R, additional, Gelincik, A, additional, Hawranek, T, additional, Hoetzenecker, W, additional, Jiménez Blanco, A, additional, Kita, K, additional, Kendirlinan, R, additional, Košnik, M, additional, Laipold, K, additional, Lang, R, additional, Marchi, F, additional, Mauro, M, additional, Nittner-Marszalska, M, additional, Poziomkowska-Gęsicka, I, additional, Pravettoni, V, additional, Preziosi, D, additional, Quercia, O, additional, Reider, N, additional, Rosiek-Biegus, M, additional, Ruiz-Leon, B, additional, Schrautzer, C, additional, Serrano, P, additional, Sin, A, additional, Ayşe Sin, B, additional, Stoevesandt, J, additional, Trautmann, A, additional, Vachová, M, additional, and Johannes Sturm, G, additional

Published
2023
Full Text
View/download PDF

8. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in leukemic cutaneous T-cell lymphoma patients

Author

Tsai, YC, primary, Schlaepfer, T, additional, Ignatova, D, additional, Chang, YT, additional, Valaperti, A, additional, Amarov, B, additional, Blanchard, G, additional, Boyman, O, additional, Maiwald, M, additional, Hoetzenecker, W, additional, Pascolo, S, additional, Fassnacht, C, additional, Iselin, C, additional, Guenova, E, additional, and Bobrowicz, M, additional

Published
2022
Full Text
View/download PDF

11. Guidelines for diagnosis, prevention, and treatment of hand eczema

Author

Thyssen, J. P., Schuttelaar, M. L. A., Alfonso, J. H., Andersen, K. E., Angelova-Fischer, I., Arents, B. W. M., Bauer, A., Brans, R., Cannavo, A., Christoffers, W. A., Crépy, M. N., Elsner, P., Fartasch, M., Filon, F. L., Giménez-Arnau, A. M., Gonçalo, M., Guzmán-Perera, M. G., Hamann, C. R., Hoetzenecker, W., Johansen, J. D., John, S. M., Kunkeler, A. C. M., Hadzavdic, S. L., Molin, S., Nixon, R., Oosterhaven, J. A. F., Rustemeyer, T., Serra-Baldrich, E., Shah, M., Simon, D., Skudlik, C., Spiewak, R., Valiukevičienė, S., Voorberg, A. N., Weisshaar, E., Agner, T., Thyssen, J. P., Schuttelaar, M. L. A., Alfonso, J. H., Andersen, K. E., Angelova-Fischer, I., Arents, B. W. M., Bauer, A., Brans, R., Cannavo, A., Christoffers, W. A., Crépy, M. N., Elsner, P., Fartasch, M., Filon, F. L., Giménez-Arnau, A. M., Gonçalo, M., Guzmán-Perera, M. G., Hamann, C. R., Hoetzenecker, W., Johansen, J. D., John, S. M., Kunkeler, A. C. M., Hadzavdic, S. L., Molin, S., Nixon, R., Oosterhaven, J. A. F., Rustemeyer, T., Serra-Baldrich, E., Shah, M., Simon, D., Skudlik, C., Spiewak, R., Valiukevičienė, S., Voorberg, A. N., Weisshaar, E., and Agner, T.

Abstract

Background: Hand eczema is a common inflammatory skin disorder. Health care providers need continuously updated information about the management of hand eczema to ensure best treatment for their patients. Objectives: To update the European Society of Contact Dermatitis guideline on the diagnosis, prevention, and treatment on of hand eczema. Method: The Guideline Development Group (GDG) was established on behalf of the ESCD. A call for interest was launched via the ESCD website and via the ESCD members' mailing list. Appraisal of the evidence for therapeutic and preventive interventions was applied and a structured method of developing consensus was used and moderated by an external methodologist. The final guideline was approved by the ESCD executive committee and was in external review on the ESCD webpage for 1 month. Results: Consensus was achieved for several statements and management strategies. Conclusion: The updated guideline should improve management of hand eczema.

Published
2022

12. Virus-induced senescence is driver and therapeutic target in COVID-19

Author

Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., Kausche, L., Firsching, T.C., Dietert, K., Schotsaert, M., Martínez-Romero, C., Singh, G., Kunz, S., Niemeyer, D., Ghanem, R., Salzer, H.J.F., Paar, C., Mülleder, M., Uccellini, M., Michaelis, E.G., Khan, A., Lau, A., Schönlein, M., Habringer, A., Tomasits, J., Adler, J.M., Kimeswenger, S., Gruber, A.D., Hoetzenecker, W., Steinkellner, H., Purfuerst, B., Motz, R., Di Pierro, F., Lamprecht, B., Osterrieder, N., Landthaler, M., Drosten, C., García-Sastre, A., Langer, R., Ralser, M., Eils, R., Reimann, M., Fan, D.N.Y., and Schmitt, C.A.

Subjects
Cancer Research, Technology Platforms
Abstract

Derailed cytokine and immune cell networks account for organ damage and clinical severity of COVID-19. Here we show that SARS-CoV-2, like other viruses, evokes cellular senescence as a primary stress response in infected cells. Virus-induced senescence (VIS) is indistinguishable from other forms of cellular senescence and accompanied by a senescence-associated secretory phenotype (SASP), composed of pro-inflammatory cytokines, extracellular matrix-active factors and pro-coagulatory mediators. COVID-19 patients displayed markers of senescence in their airway mucosa in situ and elevated serum levels of SASP factors. Mirroring COVID-19 hallmark features such as macrophage and neutrophil infiltration, endothelial damage and widespread thrombosis in affected lung tissue in vitro assays demonstrated macrophage activation with SASP-reminiscent secretion, complement lysis and SASP-amplifying secondary senescence of endothelial cells, neutrophil extracellular trap (NET) formation as well as activation of platelets and the clotting cascade in response to supernatant of VIS cells, including SARS-CoV-2-induced senescence. Senolytics such as Navitoclax and Dasatinib/Quercetin selectively eliminated VIS cells, mitigated COVID-19-reminiscent lung disease and reduced inflammation in SARS-CoV-2-driven hamster and mouse models. Our findings mark VIS as pathogenic trigger of COVID-19-related cytokine escalation and organ damage, and suggest senolytic targeting of virus-infected cells as a novel treatment option against SARS-CoV-2 and perhaps other viral infections.

Published
2021

13. Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine

Author

Bieber, T., Akdis, C., Lauener, R., Traidl-Hoffmann, C., Schmid-Grendelmeier, P., Schäppi, G., Allam, J.-P., Apfelbacher, C., Augustin, M., Beck, L., Biedermann, T., Braun-Fahrländer, C., Chew, F. T., Clavel, T., Crameri, R., Darsow, U., Deleuran, M., Dittlein, D., Duchna, H.-W., Eichenfeld, L., Eyerich, K., Frei, R., Gelmetti, C., Gieler, U., Gilles, S., Glatz, M., Grando, K., Green, J., Gutermuth, J., Guttman-Yassky, E., Hanifin, J., Hijnen, D., Hoetzenecker, W., Irvine, A., Kalweit, A., Katoh, N., Knol, E., Koren, H., Möhrenschlager, M., Münch, D., Novak, N., OʼMahony, L., Paller, A. S., Rhyner, C., Roduit, C., Schiesser, K., Schröder, J., Simon, D., Simon, H.-U., Sokolowska, M., Spuls, P., Stalder, J.-F., Straub, D., Szalai, Z., Taieb, A., Takaoka, R., Todd, G., Todorova, A., Vestergaard, C., Werfel, T., Wollenberg, A., and Ring, J.

Published
2016
Full Text
View/download PDF

16. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID 19 pandemic

Author

Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M., Untersmayr, E., Hoffmann-Sommergruber, K., Vultaggio, A., Agache, I, Bavbek, S., Bossios, A., Casper, I, Chan, S., Chatzipetrou, A., Vogelberg, C., Firinu, D., Kauppi, P., Kolios, A., Kothari, A., Matucci, A., Palomares, O., Szepfalusi, Z., Pohl, W., Hoetzenecker, W., Rosenkranz, A., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Moesges, R., Saloga, J., Staubach, P., Jappe, U., Rabe, C., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Freudelsperger, L., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Matricardi, P. M., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Idzko, M., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Jensen-Jarolim, E., Korn, S., Hentges, F., Schwarze, J., OMahony, L., Knol, E., del Giacco, S., Chivato Perez, T., Bousquet, J., Zuberbier, T., Akdis, C., Jutel, M., Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M., Untersmayr, E., Hoffmann-Sommergruber, K., Vultaggio, A., Agache, I, Bavbek, S., Bossios, A., Casper, I, Chan, S., Chatzipetrou, A., Vogelberg, C., Firinu, D., Kauppi, P., Kolios, A., Kothari, A., Matucci, A., Palomares, O., Szepfalusi, Z., Pohl, W., Hoetzenecker, W., Rosenkranz, A., Bergmann, K-C, Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Moesges, R., Saloga, J., Staubach, P., Jappe, U., Rabe, C., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Freudelsperger, L., Muelleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P-, V, Aberer, W., Fink-Wagner, A., Horak, F., Woehrl, S., Niederberger-Leppin, V, Pali-Schoell, I, Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Matricardi, P. M., Spertini, F., Khaltaev, N., Michel, J-P, Nicod, L., Schmid-Grendelmeier, P., Idzko, M., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Jensen-Jarolim, E., Korn, S., Hentges, F., Schwarze, J., OMahony, L., Knol, E., del Giacco, S., Chivato Perez, T., Bousquet, J., Zuberbier, T., Akdis, C., and Jutel, M.

Published
2020

17. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*

Author

Graier, T., primary, Salmhofer, W., additional, Jonak, C., additional, Weger, W., additional, Kölli, C., additional, Gruber, B., additional, Sator, P.G., additional, Prillinger, K., additional, Mlynek, A., additional, Schütz‐Bergmayr, M., additional, Richter, L., additional, Ratzinger, G., additional, Painsi, C., additional, Selhofer, S., additional, Häring, N., additional, Wippel‐Slupetzky, K., additional, Skvara, H., additional, Trattner, H., additional, Tanew, A., additional, Inzinger, M., additional, Tatarski, R., additional, Bangert, C., additional, Ellersdorfer, C., additional, Lichem, R., additional, Gruber‐Wackernagel, A., additional, Hofer, A., additional, Legat, F., additional, Schmiedberger, E., additional, Strohal, R., additional, Lange‐Asschenfeldt, B., additional, Schmuth, M., additional, Vujic, I., additional, Hoetzenecker, W., additional, Trautinger, F., additional, Saxinger, W., additional, Müllegger, R., additional, Quehenberger, F., additional, and Wolf, P., additional

Published
2021
Full Text
View/download PDF

26. Individualized treatment approaches for Langerhans cell histiocytosis

Author

Roider, E, Signer, C, Fehrenbacher, B, Metzler, G, Schaller, M, Kamarachev, J, Kerl, K, Balabanov, S, Jochum, W, Hoetzenecker, W, Cozzio, A, French, L, Dummer, R, Guenova, E, University of Zurich, and Guenova, E

Subjects
2708 Dermatology, 10032 Clinic for Oncology and Hematology, 10177 Dermatology Clinic, 610 Medicine & health, Dermatology
Published
2018

28. Interferon alfa‐2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement

Author

Doerschner, M., primary, Pekar‐Lukacs, A., additional, Messerli‐Odermatt, O., additional, Dommann‐Scherrer, C., additional, Rütti, M., additional, Müller, A.M., additional, Nair, G., additional, Kamarachev, J., additional, Kerl, K., additional, Beer, M., additional, Messerli, M., additional, Frauenknecht, K., additional, Haralambieva, E., additional, Hoetzenecker, W., additional, French, L.E., additional, and Guenova, E., additional

Published
2019
Full Text
View/download PDF

29. Upregulation of HLA I on tumor skin T lymphocytes as a tumor immune escape mechanism in CTCL

Author

Chang, Y.T., primary, Ziegler, M., additional, Ignatova, D., additional, Ivanov, P., additional, Profanter, R., additional, Kerl, K., additional, Hafner, J., additional, Clark, R.A., additional, Dummer, R., additional, Contassot, E., additional, French, L., additional, Misailovic, S., additional, Cozzio, A., additional, Vechev, M., additional, Hoetzenecker, W., additional, and Guenova, E., additional

Published
2019
Full Text
View/download PDF

30. Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn

Author

Higgins, R, primary, Jensen, A, additional, Wachstein, J, additional, Bruckner-Tuderman, L, additional, Spiegel, R, additional, Traber, H, additional, Achermann, J, additional, Schaller, M, additional, Fehrenbacher, B, additional, Röcken, M, additional, Ignatova, D, additional, Chang, Y, additional, Fischer, T, additional, Schwieger-Briel, A, additional, French, L, additional, Hoetzenecker, W, additional, Hornung, R, additional, Malzacher, A, additional, Cozzio, A, additional, Navarini, A, additional, Has, C, additional, and Guenova, E, additional

Published
2019
Full Text
View/download PDF

32. 595 PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

Author

Ignatova, D., primary, Kollmann, D., additional, Jedamzik, J., additional, Chang, Y., additional, Jomrich, G., additional, Baierl, A., additional, Kazakov, D., additional, Michal, M., additional, Hoetzenecker, W., additional, Schatton, T., additional, French, L.E., additional, Asari, R., additional, Preusser, M., additional, Gnant, M., additional, Schoppmann, S., additional, and Guenova, E., additional

Published
2018
Full Text
View/download PDF

33. 494 PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer

Author

Chang, Y., primary, Ignatova, D., additional, Kollmann, D., additional, Schweiger, T., additional, Schwarz, S., additional, Lewik, G., additional, Schoppmann, S., additional, Hoetzenecker, W., additional, French, L.E., additional, Klepetko, W., additional, Hoetzenecker, K., additional, and Guenova, E., additional

Published
2018
Full Text
View/download PDF

34. 1032 HLA I shield tumor skin T lymphocytes from NK-cell-mediated elimination

Author

Chang, Y., primary, Ziegler, M., additional, Ignatova, D., additional, Ivanov, P., additional, Profanter, R., additional, Kerl, K., additional, Dummer, R., additional, Contassot, E., additional, French, L.E., additional, Cozzio, A., additional, Misailovic, S., additional, Hoetzenecker, W., additional, Vechev, M., additional, and Guenova, E., additional

Published
2018
Full Text
View/download PDF

35. Individualized treatment approaches for Langerhans cell histiocytosis

Author

Roider, E., primary, Signer, C., additional, Fehrenbacher, B., additional, Metzler, G., additional, Schaller, M., additional, Kamarachev, J., additional, Kerl, K., additional, Balabanov, S., additional, Jochum, W., additional, Hoetzenecker, W., additional, Cozzio, A., additional, French, L.E., additional, Dummer, R., additional, and Guenova, E., additional

Published
2018
Full Text
View/download PDF

36. Knowledge and Influence of Predatory Journals in Dermatology: A Pan-Austrian Survey

Author

Richtig, G, primary, Richtig, M, additional, Hoetzenecker, W, additional, Saxinger, W, additional, Lange-Asschenfeldt, B, additional, Steiner, A, additional, Strohal, R, additional, Posch, C, additional, Bauer, J, additional, Müllegger, R, additional, Deinlein, T, additional, Sepp, N, additional, Volc-Platzer, B, additional, Nguyen, V, additional, Schmuth, M, additional, Hoeller, C, additional, Muehlbacher, E, additional, Pregartner, G, additional, and Richtig, E, additional

Published
2018
Full Text
View/download PDF

39. Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: Challenges and opportunities toward precision medicine

Author

MS Dermatologie/Allergologie, Infection & Immunity, CDL Celdiagnostiek, Bieber, T., Akdis, C., Lauener, R., Traidl-Hoffmann, C., Schmid-Grendelmeier, P., Schäppi, G., Allam, J. P., Apfelbacher, C., Augustin, M., Beck, L., Biedermann, T., Braun-Fahrländer, C., Chew, F. T., Clavel, T., Crameri, R., Darsow, U., Deleuran, M., Dittlein, D., Duchna, H. W., Eichenfeld, L., Eyerich, K., Frei, R., Gelmetti, C., Gieler, U., Gilles, S., Glatz, M., Grando, K., Green, J., Gutermuth, J., Guttman-Yassky, E., Hanifin, J., Hijnen, D., Hoetzenecker, W., Irvine, A., Kalweit, A., Katoh, N., Knol, E, Koren, H., Möhrenschlager, M., Münch, D., Novak, N., O'Mahony, L., Paller, A. S., Rhyner, C., Roduit, C., Schiesser, K., Schröder, J., Simon, D., Simon, H. U., Sokolowska, M., Spuls, P., Stalder, J. F., Straub, D., Szalai, Z., Taieb, A., Takaoka, R., Todd, G., Todorova, A., Vestergaard, C., Werfel, T., Wollenberg, A., Ring, J., MS Dermatologie/Allergologie, Infection & Immunity, CDL Celdiagnostiek, Bieber, T., Akdis, C., Lauener, R., Traidl-Hoffmann, C., Schmid-Grendelmeier, P., Schäppi, G., Allam, J. P., Apfelbacher, C., Augustin, M., Beck, L., Biedermann, T., Braun-Fahrländer, C., Chew, F. T., Clavel, T., Crameri, R., Darsow, U., Deleuran, M., Dittlein, D., Duchna, H. W., Eichenfeld, L., Eyerich, K., Frei, R., Gelmetti, C., Gieler, U., Gilles, S., Glatz, M., Grando, K., Green, J., Gutermuth, J., Guttman-Yassky, E., Hanifin, J., Hijnen, D., Hoetzenecker, W., Irvine, A., Kalweit, A., Katoh, N., Knol, E, Koren, H., Möhrenschlager, M., Münch, D., Novak, N., O'Mahony, L., Paller, A. S., Rhyner, C., Roduit, C., Schiesser, K., Schröder, J., Simon, D., Simon, H. U., Sokolowska, M., Spuls, P., Stalder, J. F., Straub, D., Szalai, Z., Taieb, A., Takaoka, R., Todd, G., Todorova, A., Vestergaard, C., Werfel, T., Wollenberg, A., and Ring, J.

Published
2016

41. Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma

Author

Guenova, E, Schanz, S, Hoetzenecker, W, DeSimone, J A, Mehra, T, Voykov, B, Urosevic-Maiwald, M, Berneburg, M, Dummer, R, French, L E, Kerl, K, Kamarashev, J, Fierlbeck, G, Cozzio, A, and University of Zurich

Subjects
2708 Dermatology, 10177 Dermatology Clinic, 610 Medicine & health
Published
2014

42. Expression of CD164 on Malignant T cells in Sézary Syndrome

Author

Guenova, E, primary, Ignatova, D, additional, Chang, Y, additional, Contassot, E, additional, Mehra, T, additional, Saulite, I, additional, Navarini, A, additional, Mitev, V, additional, Dummer, R, additional, Kazakov, D, additional, French, L, additional, Hoetzenecker, W, additional, and Cozzio, A, additional

Published
2016
Full Text
View/download PDF

43. Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

Author

Kleffel, S., Posch, C., Barthel, S.R., Mueller, H., Schlapbach, C., Guenova, E., Elco, C.P., Lee, N., Juneja, V.R., Zhan, Q., Lian, C.G., Thomi, R., Hoetzenecker, W., Cozzio, A., Dummer, R., Mihm, M.C., Jr, Flaherty, Kieth T., Murphy, G.F., Sharpe, A.H., Kupper, T.S., Schatton, T., Kleffel, S., Posch, C., Barthel, S.R., Mueller, H., Schlapbach, C., Guenova, E., Elco, C.P., Lee, N., Juneja, V.R., Zhan, Q., Lian, C.G., Thomi, R., Hoetzenecker, W., Cozzio, A., Dummer, R., Mihm, M.C., Jr, Flaherty, Kieth T., Murphy, G.F., Sharpe, A.H., Kupper, T.S., and Schatton, T.

Abstract

Summary Therapeutic antibodies targeting programmed cell death 1 (PD-1) activate tumor-specific immunity and have shown remarkable efficacy in the treatment of melanoma. Yet, little is known about tumor cell-intrinsic PD-1 pathway effects. Here, we show that murine and human melanomas contain PD-1-expressing cancer subpopulations and demonstrate that melanoma cell-intrinsic PD-1 promotes tumorigenesis, even in mice lacking adaptive immunity. PD-1 inhibition on melanoma cells by RNAi, blocking antibodies, or mutagenesis of melanoma-PD-1 signaling motifs suppresses tumor growth in immunocompetent, immunocompromised, and PD-1-deficient tumor graft recipient mice. Conversely, melanoma-specific PD-1 overexpression enhances tumorigenicity, as does engagement of melanoma-PD-1 by its ligand, PD-L1, whereas melanoma-PD-L1 inhibition or knockout of host-PD-L1 attenuate growth of PD-1-positive melanomas. Mechanistically, the melanoma-PD-1 receptor modulates downstream effectors of mTOR signaling. Our results identify melanoma cell-intrinsic functions of the PD-1:PD-L1 axis in tumor growth and suggest that blocking melanoma-PD-1 might contribute to the striking clinical efficacy of anti-PD-1 therapy.

Published
2015

47. 21. Mainzer Allergie-Workshop

Author

Rennert, S., primary, Krause, S., additional, Becker, W., additional, Petersen, A., additional, Schocker, F., additional, Papenfuß, K., additional, Jappe, U., additional, Brehler, R., additional, Lange, L., additional, Riffelmann, F., additional, Nemat, K., additional, Hompes, S., additional, Holzhauser, T., additional, Lidholm, J., additional, Reese, G., additional, Vieths, S., additional, Seismann, H., additional, Blank, S., additional, Braren, I., additional, Greunke, K., additional, Cifuentes, L., additional, Grunwald, T., additional, Bredehorst, R., additional, Ollert, M., additional, Spillner, E., additional, von der Gathen, Y., additional, Sander, I., additional, Flagge, A., additional, Brüning, T., additional, Raulf-Heimsoth, M., additional, Zahradnik, E., additional, Fleischer, C., additional, Schierl, R., additional, Sültz, J., additional, Nowak, D., additional, Buters, J., additional, Weichenmeier, I., additional, Ochs, S., additional, Kreyling, W., additional, Boere, A., additional, Schober, W., additional, Behrendt, H., additional, Jaeger, T., additional, Kerzl, R., additional, Huss-Marp, J., additional, Ring, J., additional, Darsow, U., additional, Roeschmann, K., additional, Vroling, A., additional, van Drunen, C., additional, Ulmer, A., additional, Gilles, S., additional, Mariani, V., additional, Zhang, X., additional, Jakob, T., additional, Müller, M., additional, Pastore, S., additional, Traidl-Hoffmann, C., additional, Oeder, S., additional, Dietrich, S., additional, Fromme, H., additional, Schäfer, V., additional, Renne, J., additional, Werfel, T., additional, Wittmann, M., additional, Grusser, M., additional, Maurer, M., additional, Dudeck, A., additional, Suender, C., additional, Heydrich, S., additional, Bros, M., additional, Wiechmann, N., additional, Besche, V., additional, Hövelmeyer, N., additional, Reissig, S., additional, Massoumi, R., additional, Grabbe, S., additional, Waisman, A., additional, Reske-Kunz, A., additional, Gschwandtner, M., additional, Roßbach, K., additional, Bäumer, W., additional, Kietzmann, M., additional, Dijkstra, D., additional, Stark, H., additional, Gutzmer, R., additional, Höhn, Y., additional, Thamsen, M., additional, Trojandt, S., additional, Bovensiepen, C., additional, Bellinghausen, I., additional, Hilmenyuk, T., additional, Saloga, J., additional, Luxemburger, U., additional, Türeci, Ö., additional, Wiesner, H., additional, Kohlrautz, V., additional, Wahn, U., additional, Stock, P., additional, Mommert, S., additional, Köther, G., additional, Sudowe, S., additional, Barwig, C., additional, Montermann, E., additional, Milovanovic, M., additional, Koch, C., additional, Hilt, K., additional, Hartmann, B., additional, Heine, G., additional, Worm, M., additional, Ambach, A., additional, Hoefeld-Fegeler, M., additional, Besser, C., additional, Weren, A., additional, Schraven, B., additional, Bonekoh, B., additional, Gollnick, H., additional, Raap, M., additional, Bruder, M., additional, Kapp, A., additional, Raap, U., additional, Grosber, M., additional, Hausteiner, C., additional, Bubel, E., additional, Groben, S., additional, Bornschein, S., additional, Lahmann, C., additional, Zilker, T., additional, Eberlein, B., additional, Henningsen, P., additional, Huber, D., additional, Biedermann, T., additional, Kunz, J., additional, Fischer, J., additional, Kempf, W., additional, Wölbing, F., additional, Alexopoulou, A., additional, Albert, A., additional, Pfaar, O., additional, Distler, A., additional, Hörmann, K., additional, Klimek, L., additional, Wieczorek, D., additional, Büsing, M., additional, Wedi, B., additional, Rerinck, H.-C., additional, Przybilla, B., additional, Ruëff, F., additional, Weigert, C., additional, Ghoreschi, K., additional, Röcken, M., additional, Muhr, P., additional, Zeitvogel, J., additional, Ott, H., additional, Wiederholt, T., additional, Andresen-Bergström, M., additional, Skazik, C., additional, Merk, H., additional, Karlberg, A., additional, Zwadlo-Klarwasser, G., additional, Baron, J., additional, Frankenberg, U., additional, Lorenz, N., additional, Steinbrink, K., additional, Pföhler, C., additional, Dietrich, K.-A., additional, Thomas, P., additional, Baran, W., additional, Hänsel, A., additional, Meurer, M., additional, Schäkel, K., additional, Mamerow, D., additional, Niebuhr, M., additional, Bonnekoh, B., additional, Bunselmeyer, B., additional, Laubach, H., additional, Schiller, M., additional, Stanke, M., additional, Luger, T., additional, Böcking, C., additional, Köllisch, G., additional, Pfefferle, P., additional, Renz, H., additional, Conrad, M., additional, Teich, R., additional, Ferstl, R., additional, Brand, S., additional, Yildirim, A., additional, Kirschning, C., additional, Garn, H., additional, Eilbacher, I., additional, Stein, K., additional, Hanuszkiewicz, A., additional, Holst, O., additional, Heine, H., additional, Guenova, E., additional, Hoetzenecker, W., additional, Mailhammer, R., additional, Weindl, G., additional, Sauer, K., additional, Schaller, M., additional, Hiller, J., additional, Förster, S., additional, Eyerich, K., additional, Hofmann, H., additional, Ilchmann, A., additional, Burgdorf, S., additional, Waibler, Z., additional, Kurts, C., additional, Scheurer, S., additional, Kalinke, U., additional, Toda, M., additional, Adler, H. S., additional, Hofmann, C., additional, Becker, C., additional, Hemmer, W., additional, Focke, M., additional, Marzban, G., additional, Mayer, D., additional, Laimer, M., additional, Jarisch, R., additional, McIntyre, M., additional, Thiebes, V., additional, Mempel, M., additional, Jeßberger, B., additional, Vrtala, S., additional, Mauss, V., additional, Eben, R., additional, Walker, A. I., additional, Herzinger, T., additional, Berking, C., additional, Reese, I., additional, Sonar, S., additional, Ehmke, M., additional, Dietze, J., additional, Nockher, W., additional, Reuter, S., additional, Dehzad, N., additional, Martin, H., additional, Jung, M., additional, Heinz, A., additional, Stassen, M., additional, Buhl, R., additional, Taube, C., additional, Lingner, S., additional, Hennig, C., additional, Remke, J., additional, Hansen, G., additional, Dittrich, A., additional, Peters, M., additional, Bufe, A., additional, Polte, T., additional, Schütze, N., additional, Simon, J., additional, Lehmann, I., additional, Albrecht, M., additional, Preston-Hurlburt, P., additional, Bottomoly, H., additional, Pilzner, C., additional, Bühling, F., additional, Reinheckel, T., additional, Lauenstein, H., additional, Braun, A., additional, Welte, T., additional, Groneberg, D., additional, Greiner, T., additional, Zimmer, A., additional, Abram, M., additional, Fokuhl, V., additional, Luger, E., additional, Radbruch, A., additional, Zemlin, M., additional, Kilic, A., additional, Yildirim, A. Ö., additional, Alrifai, M., additional, Hagner, S., additional, Renzing, A., additional, Closs, E., additional, Bopp, T., additional, Schmitt, E., additional, Dicke, T., additional, Seyfarth, F., additional, Hipler, U., additional, Elsner, P., additional, Schliemann, S., additional, Konakovsky, V., additional, Moser, P., additional, Wantke, F., additional, Sesztak-Greinecker, G., additional, Götz, M., additional, Schmid, R., additional, and Hoffmann-Sommergruber, K., additional

Published
2009
Full Text
View/download PDF

49. 376: Anti-proliferative properties of CMV hyperimmunoglobulin are related to activation induced cell death in vitro: Possible role in tolerance induction

Author

Hoetzenecker, K., primary, Hacker, S., additional, Hoetzenecker, W., additional, Sadeghi, K., additional, Pollreisz, A., additional, Mangold, A., additional, Moser, B., additional, Grimm, M., additional, Muehlbacher, F., additional, Klepetko, W., additional, Wolner, E., additional, and Ankersmit, H.J., additional

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results